Common variant heritability has been widely reported to be concentrated in variants within cell-type-specific non-coding functional annotations, but little is known about low-frequency variant functional architectures. We partitioned the heritability of both low-frequency (0.5%≤ minor allele frequency < 5%) and common (minor allele frequency ≥ 5%) variants in 40 UK Biobank traits across a broad set of functional annotations. We determined that non-synonymous coding variants explain 17 ± 1% of low-frequency variant heritability (h lf 2 ) versus 2.1 ± 0.2% of common variant heritability (h c 2 ). Cell-type-specific non-coding annotations that were significantly enriched for h c 2 of corresponding traits were similarly enriched for h lf 2 for most traits, but more enriched for brain-related annotations and traits. For example, H3K4me3 marks in brain dorsolateral prefrontal cortex explain 57 ± 12% of h lf 2 versus 12 ± 2% of h c 2 for neuroticism. Forward simulations confirmed that low-frequency variant enrichment depends on the mean selection coefficient of causal variants in the annotation, and can be used to predict effect size variance of causal rare variants (minor allele frequency < 0.5%).
C ommon variant (minor allele frequency, MAF ≥ 5%) trait heritability has been widely reported to be concentrated into non-coding functional annotations that are active in relevant cell types or tissues, with a limited role for common coding variants [1] [2] [3] [4] [5] [6] [7] [8] . Although common variants explain the bulk of heritability [9] [10] [11] , low-frequency variants can have larger per-allele effect sizes than common variants when impacted by negative selection [9] [10] [11] [12] [13] [14] [15] [16] [17] , and may thus yield important biological insights even though the heritability they explain is modest 6, 7 .
Recent large genome-wide association studies (GWAS) have identified low-frequency variants with large per-allele effect sizes and reported an excess of genome-wide significant low-frequency variants in coding regions [18] [19] [20] [21] , implying that low-frequency coding variants have larger effect sizes than other low-frequency variants. However, the relative contribution of low-frequency coding variants to low-frequency variant heritability is currently unknown. For cell-type-specific (CTS) non-coding variants, discovery of genomewide significant low-frequency variants has been limited, and their contribution to low-frequency variant heritability is also unknown. Dissecting low-frequency variant functional architectures can shed light on the action of negative selection across functional annotations and inform the design of low-frequency and rare variant association studies 14, 22 .
To investigate functional enrichments of low-frequency variants (defined here as 0.5%≤ MAF < 5%), we extended stratified linkage disequilibrium (LD) score regression 5, 23 (S-LDSC) to partition the heritability of both low-frequency and common variants. Our method produces robust (unbiased or slightly conservative) results in simulations. We applied our method to partition the heritability of low-frequency and common variants in 40 heritable traits from the UK Biobank [24] [25] [26] (average n = 363 K UK-ancestry samples) across a broad set of coding and non-coding functional annotations 5, 6, 8, 23, [27] [28] [29] [30] [31] . We performed forward simulations to connect estimated low-frequency and common variant functional enrichments to the action of negative selection, and to predict the effect size variance of causal rare variants (MAF < 0.5%) within each functional annotation.
Results
Overview of methods. S-LDSC 5,23 is a method for partitioning the heritability causally explained by common variants across overlapping discrete or continuous annotations using GWAS summary statistics for accurately imputed variants and an LD reference panel.
Here, we extended S-LDSC to partition the heritability causally explained by low-frequency variants using GWAS summary statistics for accurately imputed and poorly imputed variants. We included separate annotations for low-frequency and common variants, and used whole-genome sequencing (WGS) data from 3,567 UK10K samples 18 as an LD reference panel to ensure accurate LD information for low-frequency variants in the UK-ancestry target samples analyzed in this study (see Methods).
We jointly analyzed 163 annotations (referred as the "baseline-LF model"), including 33 main binary annotations, MAF bins, and LD-related annotations ( Supplementary Table 1 and Supplementary  Table 2 ; see Methods). We note that the inclusion of MAF-and LD-related annotations implies that the expected causal heritability
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of an SNP is a function of MAF and LD. We first estimated the heritability causally explained by all low-frequency variants (h lf 2 ) and the heritability causally explained by all common variants h ( ) c 2 . For the 33 main binary annotations, we computed their low-frequency variant enrichment (LFVE), defined as the proportion of h lf 2 causally explained by variants in the annotation divided by the proportion of low-frequency variants that lie in the annotation, and common variant enrichment (CVE), defined analogously. Further details of the method are provided in the Methods section. We have released open-source software implementing the method, and have made our annotations publicly available (see URLs).
Simulations of extending S-LDSC to low-frequency variants.
Although S-LDSC has previously been shown to produce robust results for partitioning common variant heritability using overlapping binary and continuous annotations 23, 32 , we performed additional simulations to assess our extension to low-frequency variants. We first confirmed that S-LDSC with the UK10K LD reference panel produced unbiased heritability estimates for variants with MAF ≥ 0.5% in simulations using UK10K target samples (see Supplementary Fig. 1 , Supplementary Table 3 , and Supplementary Note). We subsequently performed more realistic simulations using target samples from the UK Biobank interim release 24 , so that LD (and MAF) in the target samples and UK10K LD reference panel do not perfectly match (see Methods and Supplementary Fig. 2 ). S-LDSC was run either by restricting regression variants to accurately imputed variants (that is, INFO score 33 ≥ 0.99), as we recommended previously 5 , or by including all variants (regardless of INFO score). We focused our simulations on two representative annotations spanning roughly 1% of the genome: coding and enhancer. We considered various MAF-dependent architectures 34, 35 , and conservatively specified our generative model to be different from the additive model assumed by S-LDSC (see Methods). For each of the two annotations, we simulated scenarios with no functional enrichment ("No Enrichment") and scenarios with CVE roughly equal to 7× and lower LFVE ("Lower LFVE"), similar LFVE ("Same Enrichment"), or higher LFVE ("Higher LFVE"), respectively. For both annotations, we observed that including all variants in the regression produced slightly conservative LFVE estimates and unbiased LFVE/CVE ratio estimates, while restricting to accurately imputed variants produced upward biases ( Fig. 1 , Supplementary  Table 4 ). The slightly conservative h lf 2 and LFVE estimates are due to LD-dependent architectures (coding and enhancer variants have lower than average levels of LD, as do other enriched functional annotations 23 ) because we observed nearly unbiased estimates when creating shifted annotations with average levels of LD (see Methods and Supplementary Fig. 3 ). We thus recommend including all variants in the regression when running S-LDSC using the baseline-LF model. Our simulations indicate that this method is robust (unbiased or slightly conservative) in estimating low-frequency and common variant functional enrichments and LFVE/CVE ratios across a wide range of genetic architectures, even in the presence of poorly imputed variants, a target sample that does not exactly match the UK10K LD reference panel, and a MAF-dependent architecture that does not match the additive model assumed by S-LDSC.
Low-frequency functional architecture of UK Biobank traits.
We applied S-LDSC with the baseline-LF model to 40 polygenic, heritable complex traits and diseases from the full UK Biobank release 25 (average n = 363 K; Supplementary Table 5 ). Analyses were restricted to the set of 409 K individuals with UK ancestry 25 to ensure a close ancestry match with the UK10K LD reference panel. Summary statistics were computed by running BOLT-LMM v2.3 (ref. 26 ) on imputed dosages, which were made publicly available (see URLs). S-LDSC results were meta-analyzed across 27 independent traits (average n = 355 K; see Supplementary Note). We observed a roughly linear relationship between estimates of h c 2 and h lf 2 ( Fig. 2 and Supplementary Table 5) , with low-frequency variants explaining 6.3 ± 0.2× less heritability and having 4.0 ± 0.1× lower per-variant heritability than common variants on average. These ratios are consistent with a model in which the variance of pernormalized genotype effect sizes is proportional to − α + p p (2 (1 )) 1 (where p is the MAF; refs 34, 35 ) with α = − 0.37 (95% confidence interval (CI) [− 0.40; − 0.34]; similar to previous α estimates from raw genotype-phenotype data 10, 11 ) , and consistent with a model in which low-frequency variants have smaller per-variant heritability but larger per-allele effect sizes 10, 11, 23, 34, 35 (Supplementary Fig. 4) .
We compared the LFVE and CVE of the 33 main binary functional annotations of the baseline-LF model, meta-analyzed across traits ( Fig. 3 , Supplementary Table 6 ). LFVE were highly correlated to CVE (r = 0.79) and larger than CVE on average (regression slope = 1.85). We identified nine main functional annotations with significantly different LFVE and CVE ( Fig. 3 , Supplementary  Table 6 ). Non-synonymous variants had the largest LFVE and largest difference versus CVE (5.0× ratio; LFVE = 38.2 ± 2.3× versus CVE = 7.7 ± 0.9× ; P = 3 × 10 -36 for difference). As non-synonymous variants comprise 0.45% of low-frequency variants versus only 0.27% of common variants due to strong negative selection on nonsynonymous mutations 36, 37 (see later), this difference is even larger when comparing the proportion of heritability they explain (8.2× ratio; 17.3 ± 1.0% of h lf 2 versus 2.1 ± 0.2% of h c 2 ; P = 5 × 10 −47 ). Nonsynonymous variants predicted to be deleterious by PolyPhen-2 (ref. 29 ) had larger LFVE and LFVE/CVE ratio than non-synonymous variants predicted to be benign ( Supplementary Fig. 5 ).
We also observed LFVE significantly larger than CVE for coding variants (2.5× ratio; P = 1 × 10 −18 ), 5′ UTR (2.5× ratio; P = 1 × 10 −4 ) and the five main conserved annotations 27, 28, 30 (ratios 1.5× − 2.2× ; each P < 5 × 10 −7 ; Fig. 3 , Supplementary Table 6) . Surprisingly, phastCons regions conserved in primates 27 were more enriched than phastCons regions conserved in vertebrates or conserved in mammals 27 (even though regions conserved in more distant species may be viewed as more biologically critical). We observed that the significantly larger LFVE (compared to CVE) for all five conserved annotations was mainly due to conserved regions that were coding, and that coding enrichments were similar for regions conserved across different species ( Supplementary Fig. 6 ). Finally, we observed significantly smaller LFVE than CVE for intronic variants (0.85× ratio; P = 8 × 10 −5 ). These results were generally consistent across the 40 UK Biobank traits analyzed ( Supplementary Fig. 7 ).
We also observed significantly larger enrichment/depletion for LFVE than for CVE in the first and/or last quintile of LD-related continuous annotations related to negative selection 23 ( Supplementary Fig. 8 and Supplementary Table 7 ). Our forward simulations from ref. 23 confirmed larger effects of low-frequency variants in these LD-related annotations ( Supplementary Table 8 ). Overall, our results suggest that LFVE is substantially larger than CVE only for annotations that are strongly constrained by negative selection because the strongest differences were observed for coding and non-synonymous variants, which are known to be under strong negative selection 36, 37 . A more detailed interpretation of the LFVE/ CVE ratio is provided later (see Forward simulations).
CTS enrichments of low-frequency variants.
We sought to investigate the contribution to low-frequency variant architectures of CTS annotations [1] [2] [3] [4] [5] [6] (that is, reflecting regulatory activity in a given cell type) with excess contributions to common variant architectures. For each of the 40 UK Biobank traits, we selected the subset of 396 CTS Roadmap annotations 6 with statistically significant common variant enrichment after conditioning on (non-CTS annotations in) the baseline-LD model 5, 8 (see Methods). We selected a total of 637 trait-annotation pairs, with at least one CTS annotation for 36 of 40 traits (25 of 27 independent traits) ( Supplementary Table 9 ); the 637 CTS annotations contained 2.7% of common variants and 3.0% of low-frequency variants on average ( Supplementary Table 10 ). We analyzed each of these trait-annotation pairs using the baseline-LF model ( Fig. 4a and Supplementary Table 10 ). For the 25 trait-annotation pairs with the most statistically significant CVE for each of the 25 independent traits (critical CTS annotations), LFVE and CVE were similar, with LFVE 1.12 ± 0.13× larger than CVE on average (other definitions of critical CTS annotations produced similar conclusions; see Supplementary Fig. 9 ).
We observed Bonferroni-significant differences (after correcting each trait for 1-53 annotations tested) for two traits. The most significant trait-annotation pairs were neuroticism and H3K4me3 in brain dorsolateral prefrontal cortex (4.4× ratio; LFVE = 30.8 ± 6.4× versus CVE = 6.9 ± 1.2× ; P = 2 × 10 −4 for difference; 56.9 ± 11.7% of h lf 2 versus 11.7 ± 2.0% of h c 2 ), and age of first birth in females and H3K4me3 in brain germinal matrix (5.1× ratio; LFVE = 42.1 ± 10.2× versus CVE = 8.3 ± 1.5× ; P = 0.001; 63.2 ± 15.4% of h lf 2 versus 11.1 ± 2.0% of h c 2 ). We note that these results are not driven by the fact that H3K4me3 marks are often located in 5′ UTR and exons 38 ( Supplementary Table 10 ). Interestingly, these two annotations (and 55 of all 62 CTS annotations with LFVE/CVE > 2) are brain-specific, implicating stronger selection against variants impacting gene regulation in brain tissues (see Forward simulations and Discussion).
Although CTS annotations generally have only moderately large LFVE (for example, smaller than non-synonymous variants; Fig. 4a ), they often explain a large proportion of h lf 2 (for example, larger than non-synonymous variants; Fig. 4b ) due to large annotation size, as with CVE. In particular, H3K4me1 in regulatory T-cells (3.7% of low-frequency variants) explains 86.2 ± 20.8% of h lf 2 for All autoimmune diseases (versus 3.4% of common variants explaining 48.9 ± 9.1% of h c 2 ), and H3K4me1 in primary monocytes (4.8% of low-frequency variants) explains 79.3 ± 18.1% of h lf 2 for monocyte count (versus 4.6% of common variants explaining 70.8 ± 8.6% 
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Fig. 1 | Simulations to assess LFVe estimates.
We report estimates of LFVE and LFVE/CVE ratio in simulations under a coding-enriched architecture (first row) or enhancer-enriched architecture (second row). We considered four different simulation scenarios (see main text). S-LDSC was run either by restricting regression variants to accurately imputed variants (S-LDSC -INFO ≥ 0.99) or by including all variants (S-LDSC -All variants). We do not report LFVE/CVE ratio for the No Enrichment simulation (CVE = LFVE = 1) due to unstable estimates; however, all analyses of real traits in this paper focus on annotations with significant CVE. Results are averaged across 1,000 simulations. Error bars represent 95% CI. Numerical results for h lf 2 , h c 2 , LFVE, CVE, and LFVE/CVE ratio are reported in Supplementary Table 4 . Supplementary Table 5 .
of h c 2 ; Fig. 4b and Supplementary Table 10 ). Thus, CTS annotations often dominate low-frequency architectures, analogous to common variant architectures 5, 8 .
Larger non-synonymous enrichments in genes under selection.
Recent studies have identified gene sets that are depleted for nonsynonymous variants 31, 39 . To further investigate the connection between functional enrichment and negative selection, we stratified the CVE and LFVE of non-synonymous variants ( Fig. 3a ) based on the strength of selection on the underlying genes. We considered five bins of estimated values of selection coefficients for heterozygous protein-truncating variants 31 (s het ), with 3,073 protein-coding genes per bin, and added annotations based on non-synonymous variants within each bin to the baseline-LF model (see Methods). We determined that both the LFVE and CVE of non-synonymous variants correlated strongly with the predicted strength of selection on the underlying genes ( Fig. 5 and Supplementary Table 11 ). In particular, we observed extremely strong enrichments for nonsynonymous variants in genes under the strongest selection (bin 1: LFVE = 102.0 ± 7.9× and CVE = 41.5 ± 4.8× ). However, the LFCE/ CVE ratio was smaller for non-synonymous variants in genes under the strongest selection (bin 1: 2.5× ) than in genes under the weakest selection (bins 4 + 5: 5.8× ). We discuss this surprising result later (see Forward simulations). We obtained similar results when stratifying non-synonymous variants in genes under varying levels of selective constraint based on other related criteria ( Supplementary Fig. 10 ).
Forward simulations confirm role of negative selection. We hypothesized that the LFVE and CVE of different functional annotations would be informative for the action of negative selection, which constrains strongly selected variants to lower frequency [9] [10] [11] [12] [13] [14] [15] [16] [17] . To investigate this, we performed forward simulations 40 using a genetic architecture involving annotations mimicking non-synonymous variants (1% of the simulated genome), functional noncoding variants (1%), and ordinary non-coding variants (98%), with different respective distributions of selection coefficients s ( Supplementary Fig. 11 ). For each of these three annotations we specified the probability for a de novo variant to be deleterious (π del ), the mean selection coefficient for de novo deleterious variants (s dn ) and the probability for a deleterious variant to be causal for the trait (π del:causal ); the probability for a de novo variant to be causal for the trait is π = π del ·π del:causal . Per-allele trait effect sizes were specified to be proportional to | | τ s EW where τ EW parameterizes the coupling between selection coefficient and trait effect size in the Eyre-Walker model 12 , implying that only deleterious variants have non-zero effects (see Methods). We investigated how the LFVE and CVE of the functional non-coding annotation varied as a function of the values of s dn and π for that annotation. To achieve a realistic simulation framework, we fixed the remaining values of π del , s dn , and π for the three annotations, as well as the value of τ EW , to values that we fit using our UK Biobank estimate of 4.0× larger per-variant heritability for common versus low-frequency variants, as well as the LFVE and CVE of non-synonymous variants (38.2× and 7.7× , respectively). Specifically, we fixed π del = 60% for the functional non-coding annotation (similar results for π del = 40%; see Methods); π del = 80% (ref. 13 ), s dn = − 0.003 (ref. 13 ), and π = 8% for the nonsynonymous annotation; π del = 40%, s dn = − 0.0001, and π = 4% for the ordinary non-coding annotation; and τ EW = 0.75. We note that our fitted value of τ EW is larger than previous estimates 11, 13, 15, 16 (see Discussion).
We determined that the CVE of the functional non-coding annotation in our simulations depends on both s dn and π (Fig. 6a ), while the LFVE/CVE ratio depends primarily on s dn (Fig. 6b ). When de novo deleterious variants are under strong selection (s dn ≤ − 0.0003, corresponding to LFVE/CVE ratio ≥ 1.2× ; Fig. 6b ), the CVE depends primarily on π (Fig. 6a ) because the mean selection coefficient of deleterious common variants varies only weakly with s dn (because most deleterious common variants have s≪| | s dn ; Fig. 6c ). Finally, we observed that functional non-coding annotations with similar CVE and LFVE tend to have causal variants with slightly stronger selection coefficients (that is s dn ≈ − 0.0002) than ordinary non-coding causal variants (s dn = − 0.0001), for which LFVE is lower than CVE ( Fig. 6b ). We notes that the LFVE/CVE ratio can be used to infer the mean selection coefficient of deleterious causal variants as a function of MAF (see Fig. 6c ) because this ratio depends primarily on s dn and because the selection coefficients of de novo deleterious causal variants are drawn from a distribution with mean s dn .
Our forward simulations provide an interpretation of the LFVE/ CVE ratios of different functional annotations that we estimated for UK Biobank traits and annotations. First, they confirm that nonsynonymous variants (which are strongly deleterious 41 : large π del and | | s dn ) can have a limited contribution to common variant architectures (2.1% of h c 2 ) but a large contribution to low-frequency variant architectures (17.3% of h lf 2 ) ( Fig. 3a) . Second, they indicate that the proportion of causal variants (π ) is larger for critical CTS annotations than for non-synonymous variants (based on their CVE; Fig. 4a ), but that the causal variants in critical CTS annotations have only slightly larger selection coefficients than ordinary non-coding variants, except for some brain annotations that are under much stronger selection (much larger | | s dn , based on their LFVE/CVE ratios; Fig. 4a ). Third, they explain the extremely large CVE for non-synonymous variants inside genes predicted to be under strong negative selection 31 (large s het ; Fig. 5 ), which are expected to correspond to genes with an extremely large proportion of deleterious non-synonymous variants (large π del , implying large π = π del · π del:causal ). However, despite extremely large CVE and LFVE, this class of variants had a smaller LFVE/CVE ratio than that of non-synonymous variants inside genes predicted to be under weak selection (Fig. 5) , a surprising result that appears to suggest a smaller | | s dn (Fig. 6b ) despite the extremely large value of π del . We performed additional forward simulations to show that a larger | | s dn does not produce larger LFVE/CVE ratios for annotations with extremely large values of π del , for which the ratio between the proportion of low-frequency variants that are deleterious and the proportion of common variants that are deleterious is reduced to 1 ( Supplementary Fig. 12 ).
Although our focus is primarily on low-frequency variants (0.5%≤ MAF < 5%), we also used our forward simulation framework to draw inferences about rare variant (MAF < 0.5%) architectures of non-coding functional annotations, based on LFVE and CVE estimates from UK Biobank (Fig. 4a ). Specifically, we compared the mean squared per-allele effect size of rare causal variants in annotations mimicking functional non-coding variants and non-synonymous variants, respectively. We inferred disproportionate causal effects of rare variants in annotations under very strong selection (s dn = − 0.003, similar to non-synonymous variants 13 ), with mean squared causal effect sizes 11× , 26× , and 60× larger than annotations with s dn = − 0.0006, s dn = − 0.0003, and s dn = − 0.0002, respectively ( Fig. 6d and Supplementary Table 12 ; similar results for different choices of π , Supplementary Fig. 13 ). These results indicate that an annotation with large CVE needs to have even larger LFVE (for example, LFVE/CVE ratio ≥ 2× , corresponding to s dn ≤ − 0.0006; Fig. 6b ) in order to harbor rare causal variants with substantial mean squared effect sizes (for example, only an order of magnitude smaller than rare causal non-synonymous variants; Fig. 6d ). Unfortunately, most of the non-brain CTS annotations that we analyzed do not achieve this ratio (Fig. 4a) , motivating further work on more precise non-coding annotations (see Discussion).
Discussion
In this study, we partitioned the heritability of both low-frequency and common variants in 40 UK Biobank traits across numerous functional annotations, employing an extension of stratified LD score regression 5, 23 to low-frequency and common variants, which produces robust (unbiased or slightly conservative) results. Metaanalyzing functional enrichments across 27 independent traits, we highlighted the critical impact of low-frequency non-synonymous variants (17.3% of h lf 2 , LFVE = 38.2× ) compared to common nonsynonymous variants (2.1% of h c 2 , CVE = 7.7× ). Other annotations previously linked to negative selection, including non-synonymous variants with high PolyPhen-2 scores 29 , non-synonymous variants in genes under strong selection 31 , and LD-related annotations 23 , were also significantly more enriched for h lf 2 compared to h c 2 . Finally, at the trait level, we observed that CTS annotations 6,8 also dominate the low-frequency architecture and that significant CVE tend Supplementary Table 10 . Supplementary Table 11 .
to have similar LFVE or larger LFVE for brain-related annotations and traits. This last observation implicates the action of negative selection on low-frequency variants affecting gene regulation in the brain, and is consistent with the interaction between brain enhancers and genes under stronger purifying selection 18 , and with the excess of rare de novo mutations in regulatory elements active in fetal brain in patients with neurodevelopmental disorders 42 . Using forward simulations we demonstrated that the CVE of an annotation depends primarily on its proportion of causal variants (π ), while its LFVE/CVE ratio depends primarily on the mean selection coefficient for de novo deleterious variants (s dn ), and thus to the mean selection coefficient of causal variants (Fig. 6 ). These conclusions are consistent with previous studies of the role of selection 9-17 , including pleiotropic selection 17 , in maintaining variants with large effects on complex traits at low frequencies. Overall, our work quantifies the relationship between the strength of selection in specific functional annotations (both coding and non-coding) and lowfrequency and CVE for human diseases and complex traits, providing an interpretation of the enrichments estimated for UK Biobank traits and annotations. Our results on low-frequency variant functional architectures have several implications for downstream analyses. First, our results provide guidance for the design of association studies targeting low-frequency variants. Non-synonymous variants should be strongly prioritized at the low-frequency variant level 21 because they explain a large proportion of h lf 2 and directly implicate causal genes (and specifically implicate core disease genes rather than peripheral genes 7 ), avoiding the challenge of mapping non-coding variants to genes 43, 44 . However, we observed that all coding and UTR variants jointly explained only 26.8 ± 1.9% of h lf 2 ( Supplementary Table  6 ), providing an upper bound of the proportion of low-frequency signal captured by whole-exome sequencing (WES) studies. This underscores the advantages of large GWAS (with imputed genotypes obtained using large reference panels), compared to WES or exome chip data, for querying low-frequency variation 16 . Furthermore, using functionally informed association tests that assign higher weight to low-frequency non-synonymous variants or CTS annotations should significantly improve power in these analyses 4, 20, 45 . Second, our results provide guidance for the design of association studies targeting rare (MAF < 0.5%) variants, which require large sequencing datasets 14 . Although WES datasets have been successfully used to detect new coding variants, genes, and gene sets associated with human diseases and complex traits, there is an increasing focus on WGS that can capture rare non-coding variants. However, our LFVE and CVE results for critical CTS annotations (Fig. 4) , coupled with our predictions of causal rare variant effect size variance (Fig. 6d ), suggest that in most instances these annotations do not harbor causal variants with large mean squared effect sizes (with brain-related annotations and traits as a notable exception; also see ref. 42 ), highlighting the need for more precise non-coding annotations for prioritization in WGS. As a first step toward this goal, we estimated the LFVE and CVE of annotations constructed using a Supplementary Table 12. wide range of recently developed non-coding variant prioritization scores [46] [47] [48] [49] [50] . We identified only one annotation, defined using the top 0.5% of Eigen scores 48 , with an LFVE/CVE ratio significantly larger than 1 (1.7× ratio; LFVE = 22.0 ± 2.2× versus CVE = 13.0 ± 1.4× ; P = 7 × 10 −4 for difference; Supplementary Fig. 14) . However, even for this annotation, the LFVE/CVE ratio < 2 again implies that this annotation does not harbor causal variants with substantial mean squared effect sizes (only an order of magnitude smaller than rare causal non-synonymous variants; Fig. 6d ). Third, our results were consistent with strong coupling between selection coefficient and trait effect size (Eyre-Walker coupling parameter 12 τ EW = 0.75; robust to error bars in LFVE and CVE estimates, see Supplementary  Fig. 15 ), implicating a larger impact of negative selection on complex traits than previously reported 11, 13, 15, 16 and much larger effect sizes for rare variants in functional annotations with strong selection coefficients. This can be explained by the fact that our inference procedure explicitly allows different distributions of selection coefficients for non-synonymous and non-coding variants (s dn = − 0.003 and s dn = − 0.0001, respectively; Supplementary Fig. 16 ). Finally, the different LFVE/CVE ratios that we inferred for different functional annotations suggest it may be appropriate to allow annotationspecific α values when using the α model (per-normalized genotype effect size proportional to − α + p p (2 (1 )) 1 ; refs 10, 11, 34, 35 ). In the extreme case of non-synonymous variants, we explored different choices of α values for non-synonymous and other variants, and determined that a value of α = − 1.10 for non-synonymous variants and α = − 0.30 for other variants provided the best fit for our UK Biobank heritability and enrichment results ( Supplementary  Table 13 ).
Although our work has provided insights on low-frequency variant architectures of human diseases and complex traits, it has several limitations (see Supplementary Note). Despite these limitations, our low-frequency and CVE results convincingly demonstrate and quantify the action of negative selection across coding and non-coding functional annotations. 
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Methods
Extension of S-LDSC to low-frequency variants. S-LDSC 5,23 is a method for partitioning heritability explained by common variants across overlapping annotations (both binary and continuous 23 ) using GWAS summary statistics. More precisely, S-LDSC models the vector of per-normalized genotype effect size β as a mean-0 vector whose variance depends on D continuous-valued annotations a 1,…, a D :
where a d (j) is the value of annotation a d at variant j, and τ d represents the pervariant contribution of one unit of the annotation a d to heritability. We can thus perform a regression to infer the values of τ using the following relationship with the expected χ 2 statistic of variant j:
2 is the LD score of variant j with respect to continuous values a d (k) of annotation a d , r jk is the correlation between variant j and k in an LD reference panel, N is the sample size of the GWAS study, and b is a term that measures the contribution of confounding biases 51 . Then, the heritability causally explained by a subset of variants S can be estimated as
. We note that this definition, used here to define and estimate h c 2 and h lf 2 , is different from the definition of "SNP heritability" h g 2 (ref. 52 ), which refers to the heritability tagged by a set of genotyped and/or imputed variants.
To allow different effects for low-frequency and common variants inside a functional annotation a d , we modeled the variance of the per-normalized genotype effect sizes using different τ d for these two categories of variants. Where we consider D f functional annotations, we write: ) is an annotation equal to a d (j) if variant j is a low-frequency (respectively, common) variant and 0 otherwise. In all analyses we added one annotation containing all variants, five MAF bins for low-frequency variants, and 10 MAF bins for common variants to take into account MAFdependent effects 23, 53, 54 .
For each functional binary annotation of interest a d , we compared its LFVE and CVE, defined as the proportion of h lf 2 (respectively, h c 2 ) explained by the annotation, divided by the proportion of low-frequency (respectively, common) variants in the annotation (see Supplementary Note for a justification of the denominator). Standard errors were computed using a block jackknife procedure 5 . We note that these computations do not include the heritability causally explained by rare variants (MAF < 0.5%).
Application of S-LDSC was performed using 3,567 unrelated individuals of UK10K data set 18 (ALSPAC and TWINSUK cohorts) as an LD reference panel. This choice was made to ensure a close ancestry match between the target sample used to compute summary statistics (UK Biobank) and the LD reference panel (UK10K) because LD patterns of low-frequency variants are expected to vary across European populations 55, 56 (see Supplementary Note for more information on our application of S-LDSC). The main differences of our application of S-LDSC compared to standard S-LDSC analyses on common variants are summarized in Supplementary Table 14 .
Baseline-LF model and functional annotations. We considered 34 main functional annotations from the baseline-LD model v1.1 (27 binary and seven continuous annotations, including LD-related annotations; refs 5, 23, 57, 58 ), including coding, UTR, promoter and intronic regions, the histone marks monomethylation (H3K4me1) and trimethylation (H3K4me3) of histone H3 at lysine 4, acetylation of histone H3 at lysine 9 (H3K9ac) and two versions of acetylation of histone H3 at lysine 27 (H3K27ac), open chromatin as reflected by DNase I hypersensitivity sites, combined chromHMM and Segway predictions (which make use of many Encyclopedia of DNA Elements (ENCODE) annotations to produce a single partition of the genome into seven underlying chromatin states), three different conserved annotations, two versions of super-enhancers, FANTOM5 enhancers, typical enhancers, and six LD-related continuous annotations (see Supplementary Table 1 ).
To further dissect the set of coding variants, which was a major focus of this study, we annotated each coding variant using ANNOVAR 59 and added one synonymous and one non-synonymous annotation to our model. We also added three new annotations based on phastCons 27 conserved elements (46 way) in vertebrates, mammals and primates, and one annotation based on flanking bivalent transcription starting sites (TSS)/enhancers from Roadmap data 6 (see URLs). These six new annotations led to a total of 33 main binary annotations (see Supplementary Table 1 ).
We included 500 bp windows around each binary annotation and 100 bp windows around four of the main annotations, leading to a total of 74 main functional annotations. All annotations were then duplicated for low-frequency and common variants, as described in equation (4), except for the predicted allele age annotation 60 (which had too many missing values for low-frequency variants). Finally, we included one annotation containing all variants, 10 common variant MAF bins (as in the baseline-LD model 23 ) and five low-frequency variant five MAF bins. We thus obtained a set of 163 total annotations. We refer to this set of annotations as the "baseline-LF model" (see Supplementary Table 2 ), which we used for all our S-LDSC analyses. More details on the baseline-LF model are provided in the Supplementary Note.
We note that the inclusion of MAF and LD-related annotations in this model implies that the expected causal heritability of a SNP is a function of MAF and LD. More details on LD-related heritability models are provided in the Supplementary Note.
(that is, 3,398,397/5,353,593) to convert it into a per-variant heritability ratio. To match these ratios to a model in which the variance of per-normalized genotype effect sizes is proportional to − α + p p (2 (1 )) 1 , we used low-frequency and common variants of our LD reference panel and computed the ∕ h h c 2 lf 2 ratio using different values of α.
The CVE and LFVE of each functional annotation were compared using a two-sided z-test-these values are independent because they are computed using non-overlapping sets of variants. The regression slope of LFVE on CVE was computed with no intercept. As most of the 33 annotations are correlated, we did not attempt to assess the statistical significance of the regression slope or of the corresponding correlation between CVE and LFVE. We note that after removing the nine annotations with significantly different LFVE and CVE in Fig. 3 , LFVE remained highly correlated to CVE (r = 0.83) and only slightly larger than CVE on average (regression slope = 1.10).
For CTS analyses, we analyzed the 396 Roadmap 6 annotations constructed 8 from narrow peaks in six chromatin marks (DNase hypersensitivity, H3K27ac, H3K4me3, H3K4me1, H3K9ac, and H3K36me3) in a subset of a set of 88 primary cell types/tissues. We selected CTS annotations for which common variants are disease relevant following guidelines 8 . First, we analyzed each CTS annotation in turn using default S-LDSC (that is, not our extension to low-frequency variants) by conditioning on all the non-CTS annotations of the baseline-LD model v1.1, the union of annotations for each of the six chromatin marks, and the average of annotations for each mark (as performed in ref. 8 ). We note that our choice to switch from the baseline model 5 , as performed in ref. 8 , to the baseline-LD model (which includes MAF bins and LD-related annotations in addition to new functional annotations) was motived by our observation that the baseline model can slightly overestimate functional enrichment due to unmodeled annotations 23 . We also decided to consider only non-CTS annotations and to remove the four enhancers annotations derived from ref. 64 (absent from the baseline model and added in the baseline-LD model) because they are T-cell specific and may impact the detection of relevant cell types for traits for which T-cells are a relevant cell type (such as asthma and eczema; see Supplementary Fig. 17 ). We retained all the CTS annotations with a τ coefficient statistically larger than 0 (using P < 0.05/396), selecting a total of 637 trait-annotation pairs with at least one CTS annotation for 36 of 40 traits (all traits except high light-scatter reticulocyte count, high cholesterol, sunburn occasion, and age at menopause), including 25 of 27 independent traits ( Supplementary Table 9 ). Finally, we re-analyzed these 637 trait-annotation pairs using our extended S-LDSC with the baseline-LF model, the union of the six chromatin marks, and the average of annotations for each mark. In Fig. 4 , we report all 637 pairs for completeness, demonstrating the consistency between CVE and LFVE for CTS annotations ( Supplementary Table 10 ). However, as the 1-53 CTS annotations selected for each trait are often highly correlated with each other, we selected for each of the 25 independent traits the "most critical" CTS annotation, defined in the main text and Fig. 4 as the CTS annotation with the most statistically significant CVE. For these 25 annotations, we regressed their LFVE on their CVE with no intercept. We also considered five alternative definitions of the "most critical" CTS annotation for each trait-for each of these definitions, LFVE were similar to CVE ( Supplementary Fig. 9 ). Finally, when testing if a CTS annotation had a significantly larger LFVE than CVE, we used a trait-specific Bonferonni threshold (that is, 0.05 divided by the number of CTS annotations retained for the trait).
For gene set analyses based on the s het metric 31 , we divided variants into five bins containing the same number of genes (3,073; 3,072 for the last bin). For S-LDSC analyses, we added to the baseline-LF model two annotations for variants inside a protein-coding gene (for low-frequency and common variants, respectively; we used the 17,484 protein-genes from ref. 65 ), 10 annotations for variants inside the five gene sets, and 10 annotations for non-synonymous variants inside the five gene sets (22 annotations in total).
Forward simulations.
To investigate the connection between LFVE, CVE, and the distribution of fitness effects (DFE), we performed forward simulations under a Wright-Fisher model with selection using SLiM2 software 40 (see URLs). We simulated 1 Mb regions of genetic length 1 cM with a uniform recombination rate and a uniform mutation rate (2.36 × 10 −8 , as recommended in SLiM manual). De novo mutations had probability π del to be deleterious with a dominance coefficient of 0.5 and a selection coefficient s drawn from a gamma distribution with mean s dn and shape θ, and had probability 1− π del to be neutral (that is, s = 0). We outputted a sample of 5,000 European genomes using the out-of-Africa demographic model of ref. 66 implemented in SLiM. Then, we used Eyre-Walker model 12 to compute the per-allele effect size
where c is a constant, N e is the effective population size, s j the selection coefficient of variant j, τ EW is the coupling coefficient between selection and phenotypic effect, and ε is a normally distributed noise. Here, c was set to have a trait heritability h 2 = 0.5 (that is,
, where p j is the allele frequency of variant j), N e was set as the expected coalescent time 67 of the European population of the model 66 (6, 524) , and ε was set to 0 for simplicity. We note that we focused here on per-variant heritability (that is, β j 2 ) and not directional effects, and thus our conclusions are independent of the direction of the selection coefficient on the trait and are valid for traits that are either under direct or stabilizing selection.
Unlike our previous forward simulation framework 23 , we designed these simulations to have a realistic DFE for annotations mimicking both nonsynonymous and non-coding variants. Briefly, we created 50 non-synonymous elements with a realistic length 200 bp (10 kb in total, 1% of the 1 Mb simulated genome) separated by non-coding elements of size 14.9 kb (99% of the simulated genome; Supplementary Fig. 11a ). To mimic non-synonymous elements, we used π del = 80%, s dn = − 3.16 × 10 −3 , and θ = 0.32, as previously estimated 13 . Then, we estimated that fixing π del = 40%, s dn = − 1.00 × 10 −4 , θ = 0.32 for non-coding variants and τ EW = 0.75 provide a good fit for our UK Biobank heritability and nonsynonymous enrichment results (see Supplementary Note) .
In most subsequent simulations, we fixed the probability of a deleterious variant to be causal (π del:causal ) at 10% so that the proportion of de novo nonsynonymous variants that are causal (π , defined as π = π del ·π del:causal ) is 8% (respectively, 4% for non-coding variants). This allows non-synonymous variants to have LFVE and CVE on the same order of magnitude as the LFVE and CVE observed for the non-synonymous variants inside genes predicted to be under strong negative selection 31 (102.0× and 41.4× , respectively; Fig. 5 ). We note that we replicated our main results when using π del:causal = 5% ( Supplementary Fig. 18 ).
Next, we investigated the impact of s dn and π on a "functional non-coding" annotation. To do so, we alternately considered 200 kb functional elements as nonsynonymous elements (1% of the simulated genome) or as functional non-coding elements (1% of the simulated genome) separated by "ordinary non-coding" elements of size 9.8 kb (98% of the simulated genome; Supplementary Fig. 11b ). For each functional non-coding element, we fixed π del = 60% and θ = 0.32 (equal to the value of θ for non-synonymous and overall non-coding elements). We chose a value π del in between the value for overall non-coding (π del = 40%) and non-synonymous (π del = 80%) annotations because we hypothesized that enriched functional non-coding annotations in the human genome have a larger proportion of deleterious variants than the overall non-coding genome. However, we note that we obtained similar results when choosing π del = 40% for the functional non-coding annotation ( Supplementary Fig. 19 ). We varied s dn and π del:causal (and thus π ) of the functional non-coding annotation while retaining π del:causal = 10% for the variants in the non-synonymous and ordinary noncoding elements. (We varied s dn on the logarithmic scale and reported truncated values in the manuscript for simplicity; for example, s dn = − 0.003 stands for − 3.1623 × 10 −3 ; see Supplementary Table 12 for exact s dn values). For each scenario, we simulated 1,000 regions of 1 Mb for each scenario, merged the outputted variants, and considered 100 randomly chosen sets of causal variants.
When drawing inferences about rare variant (MAF < 0.5%) architectures of non-coding functional annotations, we focused on simulations with π = 48% for the functional non-coding annotation because the CVE and LFVE/CVE ratios for the CTS annotations in Fig. 4a (between 5 and 20, and between 1 and 2, respectively) roughly correspond to π = 48% and s dn between 0.0002 and 0.0006 (Fig. 6a, b) . 
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